Dr. Larry A. Gandle, MD

Dr. Gandle practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Zephyrhills, Florida.

Dr. Gandle's NPI, 1336109909, was assigned on March 27, 2006. Dr. Gandle graduated from Tulane School of Medicine in 1982. Dr. Gandle holds Florida license ME51803.

Dr. Gandle's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 38010 Medical Center Ave, Zephyrhills, FL 33540 in Pasco County. The practice phone is (239) 541-4633.

Dr. Gandle's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Zephyrhills, Florida. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Gandle to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gandle practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Gandle's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Gandle is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Gandle's licenses on file in 3 states: Florida, New York and Louisiana.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Gandle treats.

CMS data shows 3,219 Medicare services from Dr. Gandle across 21 procedure codes in 2024, for 213 Medicare patients. Medicare paid $523,523 for them. Every service was in an office.

CMS counts 213 Medicare patients who saw Dr. Gandle in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gandle's median patient age at 73, with 46% women.

In 2024, Dr. Gandle wrote 75 Medicare Part D claims for 41 patients. 93% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $348 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gandle for performance year 2024, reported as part of a group. Dr. Gandle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 175 general payments to Dr. Gandle from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $406.

Dmand AI lists 1 award for Dr. Gandle, most recently CMS Stage 1 EHR in 2013.

Dr. Gandle graduated from Tulane School of Medicine in 1982.

Dr. Gandle is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.